Data / Drug companies / Nitroglycerin
Nitroglycerin: 40 companies and 106 products in the FDA NDC directory
Nitroglycerin is listed in the FDA National Drug Code Directory by 40 companies, with 106 products in commercial distribution. 67 of the products (63.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; patch; ointment, and the newest product started marketing on August 10, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 40
- Products
- 106
- Generic (ANDA) products
- 67 (63.2%)
- Application numbers
- 22
- Routes
- Sublingual, Oral, Transdermal, Intravenous, Rectal
- Brand names
- Glonoinum, Nitro-Dur, Nitrostat, Nitro-Time, Rectiv, Nitrolingual, Nitro-Bid, Nitrostat
- openFDA record search
- api.fda.gov
Companies that list nitroglycerin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Boiron | 8 | pellet | Unapproved homeopathic products | March 3, 1983 |
| Dr. Reddy's Laboratories Inc. | 7 | patch; tablet | Authorized generics (NDA) | March 1, 2020 |
| HF Acquisition Co LLC, DBA HealthFirst | 6 | tablet; spray | Generic drugs (ANDA) | December 2, 2024 |
| Ingenus Pharmaceuticals, LLC | 6 | patch | New drug applications (NDA) | December 6, 2017 |
| Medical Purchasing Solutions, LLC | 6 | tablet | Generic drugs (ANDA) | September 1, 2024 |
| A-S Medication Solutions | 4 | tablet | Generic drugs (ANDA) | February 2, 2024 |
| Mylan Pharmaceuticals Inc. | 4 | patch | Generic drugs (ANDA) | June 18, 1998 |
| Advagen Pharma Ltd | 3 | tablet | Generic drugs (ANDA) | May 3, 2021 |
| Aurobindo Pharma Limited | 3 | tablet | Generic drugs (ANDA) | October 26, 2023 |
| Baxter Healthcare Corporation | 3 | injection | New drug applications (NDA) | December 29, 1989 |
| Glenmark Pharmaceuticals Inc., USA | 3 | tablet | Generic drugs (ANDA) | September 19, 2017 |
| Golden State Medical Supply, Inc. | 3 | tablet | Generic drugs (ANDA) | August 26, 2016 |
| Lifestar Pharma LLC | 3 | tablet | Generic drugs (ANDA) | December 5, 2023 |
| Mylan Pharmaceuticals Inc. | 3 | tablet | Authorized generics (NDA) | August 26, 2016 |
| Natco Pharma USA LLC | 3 | tablet | Generic drugs (ANDA) | October 3, 2022 |
| NuCare Pharmaceuticals,Inc. | 3 | tablet | Generic drugs (ANDA) | September 1, 2024 |
| Remedyrepack Inc. | 3 | tablet; injection, solution | Generic drugs (ANDA) | February 5, 2025 |
| Solco Healthcare US, LLC | 3 | tablet | Generic drugs (ANDA) | June 1, 2025 |
| Time Cap Laboratories, Inc | 3 | capsule | Other unapproved drugs | June 19, 2014 |
| Viatris Specialty LLC | 3 | tablet | New drug applications (NDA) | June 4, 2024 |
| Encube Ethicals, Inc. | 2 | ointment | Generic drugs (ANDA) | April 16, 2025 |
| Padagis Israel Pharmaceuticals Ltd | 2 | spray; ointment | Generic drugs (ANDA) | August 10, 2026 |
| ProPharma Distribution | 2 | tablet; injection | Generic drugs (ANDA) | September 19, 2017 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | October 3, 2022 |
| Redpharm Drug | 2 | tablet | Generic drugs (ANDA) | September 1, 2024 |
| Sportpharm LLC | 2 | spray; tablet | Authorized generics (NDA) | December 2, 2024 |
| Allegis Pharmaceuticals, LLC | 1 | spray | Authorized generics (NDA) | July 1, 2019 |
| Allergan, Inc. | 1 | ointment | New drug applications (NDA) | June 21, 2011 |
| American Regent, Inc. | 1 | injection, solution | Generic drugs (ANDA) | March 4, 2003 |
| Bryant Ranch Prepack | 1 | ointment | Generic drugs (ANDA) | January 8, 2026 |
| Cosette Pharmaceuticals, Inc. | 1 | ointment | Generic drugs (ANDA) | February 23, 2024 |
| Henry Schein, Inc. | 1 | injection, solution | Generic drugs (ANDA) | January 13, 2022 |
| Independence Pharmaceuticals, LLC | 1 | spray | New drug applications (NDA) | December 2, 2024 |
| NorthStar RxLLC | 1 | tablet | Generic drugs (ANDA) | September 1, 2024 |
| Prasco Laboratories | 1 | spray | Authorized generics (NDA) | December 2, 2024 |
| Proficient Rx LP | 1 | tablet | New drug applications (NDA) | May 1, 2000 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | August 29, 2016 |
| Savage Laboratories a Division of Fougera Pharmaceuticals, LLC | 1 | ointment | Generic drugs (ANDA) | August 15, 2009 |
| Solaris Pharma Corporation | 1 | ointment | Generic drugs (ANDA) | January 8, 2026 |
| TruPharma, LLC | 1 | ointment | Generic drugs (ANDA) | December 2, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 57 | 53.8% |
| Patch | 14 | 13.2% |
| Ointment | 10 | 9.4% |
| Pellet | 8 | 7.5% |
| Spray | 6 | 5.7% |
| Injection | 4 | 3.8% |
| Injection, solution | 4 | 3.8% |
| Capsule | 3 | 2.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 67 | 63.2% |
| New drug applications (NDA) | 18 | 17% |
| Authorized generics (NDA) | 10 | 9.4% |
| Unapproved homeopathic products | 8 | 7.5% |
| Other unapproved drugs | 3 | 2.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Nitrate Vasodilator | 106 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.